Trichomonas vaginalis infection and risk of advanced prostate cancer
- 28 January 2016
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 76 (7) , 620-623
Abstract
BACKGROUND The epidemiologic evidence for an association of Trichomonas vaginalis (Tv) with overall prostate cancer is mixed, but some studies suggest Tv may increase risk of more aggressive disease. The aim of this study was to assess whether Tv serostatus is associated with advanced or fatal prostate cancer. METHODS A total of 146 men with advanced (metastatic or fatal) prostate cancer and 181 age‐matched controls were selected from two prior population‐based, case‐control studies. Tv serostatus was determined with the same laboratory methods used in previous epidemiologic studies. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using multivariable logistic regression to compare Tv serostatus in prostate cancer cases and controls adjusted for potential confounders. RESULTS The seroprevalence of Tv in controls was 23%. Tv serostatus was not associated with an increased risk of metastatic or fatal prostate cancer (ORs < 1). CONCLUSIONS Our study does not support an increased risk of advanced or fatal prostate cancer in men seropositive for Tv. Prostate 76:620–623, 2016.Keywords
Funding Information
- National Institutes of Health (R01 CA056678, R01 CA092579, P50 CA097186)
- Fred Hutchinson Cancer Center
- Prostate Cancer Foundation Young Investigator Award
This publication has 8 references indexed in Scilit:
- Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responsesProceedings of the National Academy of Sciences, 2014
- Epitopes of the Highly Immunogenic Trichomonas vaginalis α-Actinin Are Serodiagnostic Targets for Both Women and MenJournal of Clinical Microbiology, 2013
- Trichomonosis, a Common Curable STI, and Prostate Carcinogenesis—A Proposed Molecular MechanismPLOS Pathogens, 2012
- Prospective Study of Trichomonas vaginalis Infection and Prostate Cancer Incidence and Mortality: Physicians' Health StudyJNCI: Journal of the National Cancer Institute, 2009
- Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention TrialInternational Journal of Cancer, 2009
- Statin Use and Risk of Prostate Cancer: Results from a Population-based Epidemiologic StudyAmerican Journal of Epidemiology, 2008
- Plasma Antibodies against Trichomonas vaginalis and Subsequent Risk of Prostate CancerCancer Epidemiology, Biomarkers & Prevention, 2006
- Vasectomy and risk of prostate cancer.1999